CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2.21B, above the global median of $1.15B
- FinancialsAltman Z-Score 7.66: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
14.87BCNY2.21B · vs all stocks (USD)
Revenue (TTM)
417.21MCNY61.96M · vs all stocks (USD)
Profit Margin
-51.60%Beta
1.19xvs all stocks
52-Week Change
-31.30%vs all stocks
Market Capitalization
14.87BCNY2.21B · vs all stocks (USD)
Enterprise Value
16.02BCNY2.38B · vs all stocks (USD)
Forward P/E
140.59xPrice to Sales (TTM)
37.57xPrice to Book (MRQ)
62.28xEnterprise to Revenue
38.39xGross Margin
66.95%Profit Margin
-51.60%Operating Margin
-17.51%Return on Assets (TTM)
-5.96%Return on Equity (TTM)
-70.95%Revenue (TTM)
417.21MCNY61.96M · vs all stocks (USD)
Revenue per Share (TTM)
2.62CNYUpdated Aug 19, 2026Quarterly Revenue Growth
0.90%Gross Profit (TTM)
226.27MCNY33.61M · vs all stocks (USD)
EBITDA (TTM)
2.67MCNY395.83K · vs all stocks (USD)
Net Income (TTM)
-215.28MCNY-31.97M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-14.50%Operating Cash Flow (TTM)
-42.59MCNY-6.32M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-94.66MCNY-14.06M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
68.77MCNYFY2025 · Dec 31, 2025Revenue
416.37MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
156.88MCNYFY2025 · Dec 31, 2025Gross Profit
259.49MCNYFY2025 · Dec 31, 2025Operating Income
-85.95MCNY-12.77M · vs all stocks (USD)
Pre-tax Income
-229.25MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.58MCNYFY2025 · Dec 31, 2025Net Income
-241.83MCNYFY2025 · Dec 31, 2025EBIT
-196.40MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.67MCNYFY2025 · Dec 31, 2025Research & Development
31.83MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
169.33MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.42MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
418.38KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
32.85MCNYFY2025 · Dec 31, 2025EPS (Basic)
-1.37CNYFY2025 · Dec 31, 2025EPS (Diluted)
-1.37CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
159.27MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
159.27MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-241.83MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
23.98MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-268.85MCNYFY2025 · Dec 31, 2025Free Cash Flow
-328.38MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
205.73MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-241.83MCNYFY2025 · Dec 31, 2025Other Non-cash Items
38.76MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-19.11MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-46.68MCNYFY2025 · Dec 31, 2025Capital Expenditures
-59.52MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.55MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-62.07MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
320.50MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-327.15MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-15.36MCNYFY2025 · Dec 31, 2025Other Financing Charges
181.91MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
159.90MCNYFY2025 · Dec 31, 2025Shares Outstanding
159.27MSharesUpdated Aug 19, 2026Float Shares
94.11MSharesUpdated Aug 19, 2026% Held by Insiders
47.75%vs all stocks
% Held by Institutions
3.44%vs all stocks
Total Cash (MRQ)
208.55MCNY30.97M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.31CNYUpdated Aug 19, 2026Total Debt (MRQ)
486.96MCNY72.32M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.54xCurrent Ratio (MRQ)
1.02xBook Value per Share (MRQ)
1.58CNYUpdated Aug 19, 2026Total Assets
1.40BCNY208.00M · vs all stocks (USD)
Total Current Assets
511.42MCNYFY2025 · Dec 31, 2025Total Liabilities
1.05BCNYFY2025 · Dec 31, 2025Total Non-current Assets
889.06MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
582.16MCNYFY2025 · Dec 31, 2025Total Current Liabilities
472.02MCNYFY2025 · Dec 31, 2025Cash
205.73MCNYFY2025 · Dec 31, 2025Cash Equivalents
8.20MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
213.93MCNYFY2025 · Dec 31, 2025Accounts Receivable
76.25MCNYFY2025 · Dec 31, 2025Inventory
124.85MCNYFY2025 · Dec 31, 2025Accounts Payable
186.48MCNYFY2025 · Dec 31, 2025Short-term Debt
211.84MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.24MCNYFY2025 · Dec 31, 2025Long-term Debt
244.13MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
275.59MCNYFY2025 · Dec 31, 2025Common Stock (Book)
159.27MCNYFY2025 · Dec 31, 2025Retained Earnings
-669.26MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
346.30MCNY51.43M · vs all stocks (USD)
52-Week Low
79.00CNYUpdated Aug 19, 202652-Week High
156.22CNYUpdated Aug 19, 202652-Week Change
-31.30%vs all stocks
Beta
1.19xvs all stocks
50-Day MA
93.99CNYUpdated Aug 19, 2026200-Day MA
103.23CNYUpdated Aug 19, 2026Avg 10-Day Volume
7.31MSharesUpdated Aug 19, 2026Avg 30-Day Volume
7.59MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-1.35CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 37.57Revenue Growth YoY: 0.01
High gross margins eroded by operating costsNotable
Gross Margin: 0.67Profit Margin: -0.52
Financial Health
Altman Z-Score 7.66: safe zoneNotable
Altman Z-Score: 7.66
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2.21B, above the global median of $1.15BNotable
Market cap (USD): 2,208,605,244.011Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Wedge Industrial Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Mesoblast Limited
Tier 1ProductionApproval-Gated PipelineRule
MeHow Innovative Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sionna Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Iovance Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zai Lab Limited
Tier 1ProductionApproval-Gated PipelineRuleRisk
Neogen Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Granules India Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pfizer Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pavella Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Spire Global Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Ars Pharmaceuticals Inc
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Sarepta Therapeutics Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated